T cell receptors and related materials and methods of use

Details T cell receptors and related materials and methods of use T cell receptors and related materials and methods of use

2008-08-22

2010-10-26

Skelding, Zachary (Department: 1644)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Fusion protein or fusion polypeptide

C530S386000

Reexamination Certificate

active

07820174

ABSTRACT:
The invention provides an isolated or purified T cell receptor (TCR) having antigenic specificity for a cancer antigen, e.g., a renal cell carcinoma antigen, wherein the TCR recognizes the cancer antigen in a major histocompatibility complex (MHC)-independent manner. Also provided are related polypeptides, proteins, nucleic acids, recombinant expression vectors, isolated host cells, populations of cells, antibodies, or antigen binding portions thereof, and pharmaceutical compositions. The invention further provides a method of detecting the presence of cancer in a host and a method of treating or preventing cancer in a host using the inventive TCRs or related materials.

REFERENCES:
patent: 6800746 (2004-10-01), Xu et al.
patent: 2005/0009025 (2005-01-01), Jakobsen et al.
patent: 2006/0263334 (2006-11-01), Finn et al.
patent: 1 275 400 (2003-01-01), None
patent: WO 01/73032 (2001-10-01), None
patent: WO 03/000928 (2003-01-01), None
patent: WO 2005/056595 (2005-06-01), None
patent: WO 2007/100568 (2007-09-01), None
George Miklos, Nat Biotechnol. May 2005;23(5):535-7.
Janeway et al., Immunobiology, 5th Ed., Garland Science, pp. 105-108; 262-263.
Portolano et al., J Immunol. Feb. 1, 1993;150(3):880-7.
Gras et al., Curr Opin Immunol. Feb. 2008;20(1):119-25.
Boulter et al. Protein Eng. Sep. 2003;16(9):707-11.
Alajez et al.,Blood, 105 (12), 4583-4589 (2005).
Barnd et al.,Proc. Natl. Acad. Sci. USA, 86, 7159-7163 (1989).
Choudhary et al.,J. Immunol., 154, 3932-3940 (1995).
EBI Database Accession No. AAU69943 (2002).
Engels et al.,Hum. Gene Ther., 16 (7), 800-802 (2005).
GenBank Accession No. AAB24537.1 (1993).
GenBank Accession No. AAB69013 (2002).
GenBank Accession No. AAC80217.1 (2005).
Hanada et al.,Cancer Res., 61, 5511-5516 (2001).
Hanada et al.,Nature, 427, 252-256 (2004).
Holoshitz et al.,Curr. Topics in Microbio. and Immunol., 173, 167-172 (1991).
Itoh et al.,J. Exp. Med., 168, 1419-1441 (1988).
Jantzer et al.,Cancer Res., 58 (14), 3078-3086 (1998).
Kirri et al.,J. Immunol., 21, 188-197 (1998).
Leroy et al.,Am. J. Clin. Pathol., 118, 47-51 (2002) (Abstract).
Magarian-Blander et al.,J. Immunol., 160, 3111-3120 (1998).
Morita et al.,Reg. Immunol., 4 (4), 225-235 (1992).
Patel et al.,J. Immunol., 139 (11), 3886-3895 (1987).
Schendel et al.,J. Mol. Med., 75 (6), 400-413 (1997).
Thiele et al.,Immunol. Today, 10, 375-381 (1989).
Wang et al.,J. Immunother., 28 (6), 551-559 (2005).
EBI Database Accession No. AX658301, May 31, 2006.

Affiliated with

Also associated with

Rating

T cell receptors and related materials and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with T cell receptors and related materials and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and T cell receptors and related materials and methods of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4155330